- Home
- HHS vs TELA Comparison
HHS vs TELA Comparison
Compare HHS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- TELA
- Stock Information
- Founded
- HHS 1923
- TELA 2012
- Country
- HHS United States
- TELA United States
- Employees
- HHS 2003
- TELA N/A
- Industry
- HHS Advertising
- TELA Medical/Dental Instruments
- Sector
- HHS Consumer Discretionary
- TELA Health Care
- Exchange
- HHS Nasdaq
- TELA Nasdaq
- Market Cap
- HHS 30.3M
- TELA 36.4M
- IPO Year
- HHS N/A
- TELA 2019
- Fundamental
- Price
- HHS $3.83
- TELA $1.68
- Analyst Decision
- HHS
- TELA Strong Buy
- Analyst Count
- HHS 0
- TELA 4
- Target Price
- HHS N/A
- TELA $6.00
- AVG Volume (30 Days)
- HHS 6.3K
- TELA 181.8K
- Earning Date
- HHS 08-07-2025
- TELA 08-11-2025
- Dividend Yield
- HHS N/A
- TELA N/A
- EPS Growth
- HHS N/A
- TELA N/A
- EPS
- HHS N/A
- TELA N/A
- Revenue
- HHS $181,355,000.00
- TELA $71,217,000.00
- Revenue This Year
- HHS $6.54
- TELA $26.67
- Revenue Next Year
- HHS N/A
- TELA $22.63
- P/E Ratio
- HHS N/A
- TELA N/A
- Revenue Growth
- HHS N/A
- TELA 12.78
- 52 Week Low
- HHS $3.65
- TELA $0.86
- 52 Week High
- HHS $8.87
- TELA $5.56
- Technical
- Relative Strength Index (RSI)
- HHS 32.77
- TELA 55.94
- Support Level
- HHS $3.85
- TELA $1.48
- Resistance Level
- HHS $4.40
- TELA $1.80
- Average True Range (ATR)
- HHS 0.28
- TELA 0.21
- MACD
- HHS -0.04
- TELA -0.03
- Stochastic Oscillator
- HHS 16.43
- TELA 49.33
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.